And even after the significant gains it has experienced in recent years, it might still be early enough to get on the ...

Global companies have been hit with a brutal $320 billion in lost profit since 2017, and it has nothing to do with bad ...

Key Points CRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential ...

Almost 3,500 listed companies globally that have annual revenues above $1bn lost a combined $320bn in profit during periods of geopolitical and macro volatility, a study by EY-Parthenon, the strategy ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

The Antibiotics Market value was US$ $$ billion in 2022. The Antibiotics Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% during the ...

The Peptide Therapeutics Market value was US$ $$ billion in 2022. The Peptide Therapeutics Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% ...

Lab Africa co-located with IFAT Africa. 138 exhibitors from 12 countries at analytica Lab Africa Event reinforces global analytica trade show prominence Sustainability, digital transformation & ...

Trump has rolled back many of his steepest tariffs over recent months, including a sky-high levy on China, the top source of ...

According to Research by SNS Insider, U.S. Cancer Biomarkers Market to Surpass USD 22.70 Billion by 2032 Due to Rising Investment in Personalized Cancer Diagnostics.Austin, July 21, 2025 (GLOBE ...

Johnson & Johnson is making headlines with shifting analyst ratings and price target adjustments. Guggenheim raised its ...